This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Sign In   |   Register
News: Congress

EAS 2018 Video interview: Dr. Arash Haghikia on Gut microbiota

Monday 7 May 2018   (0 Comments)
Share |

The role of the gut microbiota is much in the news. At EAS Congress Lisbon 2018, Dr. Arash Haghikia, Department of Cardiology, Charité - Universitätsmedizin Berlin, Germany discusses recent findings from a study evaluating the potential for a metabolite derived from the gut microbiota, TMAO (trimethylamine-N-oxide), as a prognostic marker in secondary prevention.

Membership Software Powered by YourMembership  ::  Legal